Critical minerals, defence technology and development-stage healthcare are driving a heavy volume of investor attention on HotCopper this week, with several small-cap names coming firmly under the microscope as Australia's largest stock forum dissects the latest company news. Discussion volume on the platform, which hosts threads on ASX-listed companies large and small, is often treated as a rough barometer of where retail attention is sitting, and this week's most-viewed names each carry a fresh news catalyst.

American Tungsten & Antimony (ASX:AT4)

American Tungsten & Antimony was one of the most actively discussed names on the forum, with the company continuing to draw interest around its US-focused tungsten and antimony strategy. The company lodged a cleansing notice on Monday, while recent drilling at its Antimony Canyon project has provided the backdrop for renewed investor interest in the high-grade antimony story. Both metals are designated critical minerals by the US government, and China, the dominant global producer of each, imposed export controls on antimony in 2024, a move that drove prices to record highs and intensified Western interest in non-Chinese supply. That policy backdrop frames shareholder focus on AT4's exposure to US critical minerals and the potential significance of its antimony and tungsten assets, with the speculative nature of the story continuing to shape the conversation.

DroneShield (ASX:DRO)

DroneShield was another major focus after launching RfRecon, a new portable radio-frequency intelligence product described by the company as the next generation of its RF detection technology. Monday's announcement gave investors a fresh product catalyst to debate. Counter-drone demand has accelerated globally as drone warfare in Ukraine and expanding civilian drone use push governments and infrastructure operators to invest in detection and mitigation systems, and DroneShield remains one of the few ASX-listed pure plays on that theme. The launch has nonetheless produced a familiar split in HotCopper discussion, with the bullish camp concentrating on DroneShield's expanding product suite and demand for counter-drone technology, while others remain focused on valuation, execution and the company's ability to convert a strong thematic opportunity into sustained commercial growth.

Liontown Resources (ASX:LTR)

Liontown Resources also remained firmly in the conversation as investors turned their attention to the Kathleen Valley lithium operation and the broader recovery in lithium sentiment. Kathleen Valley entered production in 2024, making Liontown one of the few ASX-listed names bringing a large new lithium mine up through a downturn that saw sliding prices force curtailments and project deferrals across the industry. Recent company material has kept the focus on operational performance, the production ramp-up and the financial capacity being created as the mine advances, while investor attention has increasingly shifted towards what stronger lithium pricing could mean for an established producer such as Liontown.

Dateline Resources (ASX:DTR)

Among the most-watched stocks, Dateline Resources generated particularly intense attention after a US court issued a preliminary injunction affecting operations at the Colosseum gold project in California. The company updated the market on the US proceedings on Wednesday, making the legal dispute the immediate focus for investors and sending the stock sharply lower before it subsequently rebounded. The episode is a reminder that Australian juniors operating overseas carry legal and administrative risks that can move share prices sharply regardless of project fundamentals, and investor attention is now concentrated on the implications of the court proceedings and what happens next.

4DMedical (ASX:4DX)

4DMedical continued to attract significant views as investors assessed the company's commercialisation trajectory following its recent US expansion and ongoing development of its lung-imaging technology. The company's software maps regional lung ventilation at a level of detail conventional imaging does not provide and has secured US regulatory clearance, anchoring a commercialisation strategy that spans clinical referrals and pharmaceutical research contracts. This week's activity included an update on the proposed issue of securities and subsequent applications for quotation, keeping the stock active across the company's HotCopper community even without a new major clinical catalyst.

Anson Resources (ASX:ASN)

For Anson Resources, attention has been particularly intense around its Green River lithium project, a brine-focused project in Utah's Paradox Basin, and the shareholder meeting the company held in Perth on Friday. The meeting was focused on resolutions concerning the board, including proposals relating to the removal of existing directors and the appointment of new board members, making governance and capital allocation central themes in this week's investor discussion. One prominent shareholder campaign has argued for changes to the board structure and a strategic review, while other investors remain focused on the potential of Green River itself.

This article is provided for information only and does not constitute investment advice. Readers are encouraged to conduct their own research and consult a certified financial adviser before making any investment decisions.